PharmaShots | Incisive News in 3 Shots

Subscribe Now

infections

F2G Receives the US FDA's Breakthrough Therapy Designation for Olorofim

F2G Receives the US FDA's Breakthrough Therapy Designation for Olorofim

October 22, 2020

Merck Reports Acceptance of NDA from FDA for Its (Imipenem/Cilastatin) + (Relebactam) for Complicated Urinary Tract and Intra-Abdominal Infections in Adults

Merck Reports Acceptance of NDA from FDA for Its (Imipenem/Cilastatin) + (Relebactam) for Complicated Urinary Tract and Intra-Abdo...

February 6, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us